IN2014DN06995A - - Google Patents
Info
- Publication number
- IN2014DN06995A IN2014DN06995A IN6995DEN2014A IN2014DN06995A IN 2014DN06995 A IN2014DN06995 A IN 2014DN06995A IN 6995DEN2014 A IN6995DEN2014 A IN 6995DEN2014A IN 2014DN06995 A IN2014DN06995 A IN 2014DN06995A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutical composition
- solid pharmaceutical
- elutable
- benzothiophen
- azetidin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012035710 | 2012-02-22 | ||
PCT/JP2013/054268 WO2013125617A1 (ja) | 2012-02-22 | 2013-02-21 | 1-(3-(2-(1-ベンゾチオフェン-5-イル)エトキシ)プロピル)アゼチジン-3-オールまたはその塩を含有する固形医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN06995A true IN2014DN06995A (da) | 2015-04-10 |
Family
ID=49005796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN6995DEN2014 IN2014DN06995A (da) | 2012-02-22 | 2013-02-21 |
Country Status (14)
Country | Link |
---|---|
US (1) | US9872914B2 (da) |
EP (1) | EP2818165B1 (da) |
JP (1) | JP6054940B2 (da) |
KR (1) | KR102070581B1 (da) |
CN (1) | CN104159583B (da) |
BR (1) | BR112014020434B1 (da) |
CA (1) | CA2865380C (da) |
DK (1) | DK2818165T3 (da) |
ES (1) | ES2721666T3 (da) |
IN (1) | IN2014DN06995A (da) |
PL (1) | PL2818165T3 (da) |
RU (1) | RU2625767C2 (da) |
TR (1) | TR201907882T4 (da) |
WO (1) | WO2013125617A1 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX369549B (es) * | 2012-04-27 | 2019-11-12 | Merck Patent Gmbh | Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento. |
WO2015115512A1 (ja) * | 2014-01-29 | 2015-08-06 | 独立行政法人産業技術総合研究所 | シクロデキストリンの利用による抗がん活性が増強されたアシュワガンダ葉の水抽出物の調製方法、及びアシュワガンダ葉を含む医薬組成物 |
KR20180097581A (ko) | 2015-12-25 | 2018-08-31 | 토야마 케미칼 컴퍼니 리미티드 | 1-(3-(2-(1-벤조티오펜-5-일)에톡시)프로필)아제티딘-3-올 또는 그 염을 포함하는 정제 |
JP7057287B2 (ja) * | 2016-12-28 | 2022-04-19 | 富士フイルム富山化学株式会社 | 医薬組成物 |
JP7079209B2 (ja) * | 2016-12-28 | 2022-06-01 | 富士フイルム富山化学株式会社 | 医薬組成物およびその製造方法 |
CN110167551B (zh) * | 2016-12-28 | 2022-06-14 | 富士胶片富山化学株式会社 | 医药组合物 |
WO2018124281A1 (ja) * | 2016-12-28 | 2018-07-05 | 富山化学工業株式会社 | 外用組成物 |
RU2739199C1 (ru) * | 2017-06-02 | 2020-12-21 | ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. | Лекарственное средство для предотврашения или лечения таупатии |
MX2019014306A (es) * | 2017-06-02 | 2022-06-09 | Fujifilm Toyama Chemical Co Ltd | Agente para reducir la cantidad de proteina beta amiloide. |
EP3636262A4 (en) | 2017-06-02 | 2020-06-10 | FUJIFILM Toyama Chemical Co., Ltd. | AGENT FOR PREVENTING OR TREATING ALZHEIMER-LIKE DEMENTIA |
MX2019014310A (es) * | 2017-06-02 | 2022-06-10 | Fujifilm Toyama Chemical Co Ltd | Agente para prevenir o tratar atrofia cerebral. |
CA3067455C (en) * | 2017-06-02 | 2021-11-23 | Fujifilm Toyama Chemical Co., Ltd. | Agent for preventing or treating spinocerebellar ataxia |
WO2019088083A1 (ja) | 2017-10-30 | 2019-05-09 | 富士フイルム富山化学株式会社 | エモパミル結合タンパク質結合剤およびその利用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002088374A1 (fr) * | 2001-04-27 | 2002-11-07 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Processus de production d'isomaltose et utilisation de celui-ci |
JP4905752B2 (ja) | 2001-07-24 | 2012-03-28 | エスティー・ラボ株式会社 | 揮発性有機塩素化合物センサ |
PL217872B1 (pl) | 2001-10-19 | 2014-08-29 | Toyama Chemical Co Ltd | Pochodna eteru alkilowego lub jej sól, stanowiąca 1-{3-[2-(1-benzotiofen-5-ylo)etoksy]propylo}-3-azetydynol lub jego sól |
US7118765B2 (en) * | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
JP4090309B2 (ja) | 2002-08-30 | 2008-05-28 | 帝人株式会社 | 全芳香族ポリエステルカーボネート系樹脂組成物 |
AU2004229283B2 (en) | 2003-04-17 | 2009-02-05 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
US7838029B1 (en) * | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
EP1817009A2 (en) * | 2004-11-24 | 2007-08-15 | Spi Pharma, Inc. | Orally disintegrating compositions |
CA2600381C (en) | 2005-03-28 | 2013-11-12 | Toyama Chemical Co., Ltd. | Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol or salts thereof |
RU2397169C2 (ru) * | 2005-03-28 | 2010-08-20 | Тояма Кемикал Ко., Лтд. | Способ получения 1-(3-(2-(1-бензотиофен-5-ил)этокси) пропил)азетидин-3-ола или его солей |
JP2007137802A (ja) | 2005-11-16 | 2007-06-07 | Takeda Chem Ind Ltd | 錠剤の製造法 |
US20070196494A1 (en) * | 2006-02-17 | 2007-08-23 | Arnaud Grenier | Low-friability, patient-friendly orally disintegrating formulations |
US20090208576A1 (en) * | 2006-03-31 | 2009-08-20 | Gandhi Anilkumar S | Orally Disintegrating Tablets |
US8119625B2 (en) * | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
KR20090038471A (ko) * | 2006-08-04 | 2009-04-20 | 토야마 케미칼 컴퍼니 리미티드 | 알킬에테르 유도체 또는 그 염을 함유하는 프로테인키나제 c 활성촉진제 |
EP2211836A2 (en) * | 2007-10-10 | 2010-08-04 | Rubicon Research Private Limited | Taste-masked orally disintegrating tablets of memantine hydrochloride |
EP2287160B1 (en) * | 2008-05-28 | 2014-05-07 | Toyama Chemical Co., Ltd. | Benzothiophene oxide derivative and salt thereof |
-
2013
- 2013-02-21 IN IN6995DEN2014 patent/IN2014DN06995A/en unknown
- 2013-02-21 TR TR2019/07882T patent/TR201907882T4/tr unknown
- 2013-02-21 PL PL13752248T patent/PL2818165T3/pl unknown
- 2013-02-21 ES ES13752248T patent/ES2721666T3/es active Active
- 2013-02-21 EP EP13752248.8A patent/EP2818165B1/en active Active
- 2013-02-21 CN CN201380010472.9A patent/CN104159583B/zh active Active
- 2013-02-21 KR KR1020147023511A patent/KR102070581B1/ko active IP Right Grant
- 2013-02-21 US US14/379,960 patent/US9872914B2/en active Active
- 2013-02-21 CA CA2865380A patent/CA2865380C/en active Active
- 2013-02-21 JP JP2014500753A patent/JP6054940B2/ja active Active
- 2013-02-21 DK DK13752248.8T patent/DK2818165T3/da active
- 2013-02-21 BR BR112014020434-9A patent/BR112014020434B1/pt active IP Right Grant
- 2013-02-21 WO PCT/JP2013/054268 patent/WO2013125617A1/ja active Application Filing
- 2013-02-21 RU RU2014138035A patent/RU2625767C2/ru active
Also Published As
Publication number | Publication date |
---|---|
EP2818165A1 (en) | 2014-12-31 |
CA2865380A1 (en) | 2013-08-29 |
PL2818165T3 (pl) | 2019-09-30 |
US9872914B2 (en) | 2018-01-23 |
EP2818165B1 (en) | 2019-04-10 |
CA2865380C (en) | 2019-10-29 |
CN104159583B (zh) | 2018-04-13 |
KR20150001720A (ko) | 2015-01-06 |
CN104159583A (zh) | 2014-11-19 |
US20150045345A1 (en) | 2015-02-12 |
DK2818165T3 (da) | 2019-06-03 |
JP6054940B2 (ja) | 2016-12-27 |
BR112014020434B1 (pt) | 2021-10-13 |
ES2721666T3 (es) | 2019-08-02 |
KR102070581B1 (ko) | 2020-01-29 |
RU2014138035A (ru) | 2016-04-10 |
BR112014020434A2 (da) | 2017-06-20 |
TR201907882T4 (tr) | 2019-06-21 |
RU2625767C2 (ru) | 2017-07-18 |
WO2013125617A1 (ja) | 2013-08-29 |
JPWO2013125617A1 (ja) | 2015-07-30 |
EP2818165A4 (en) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN06995A (da) | ||
HK1216015A1 (zh) | 含有鋅氨基酸/三甲基甘氨酸鹵化物的個人清潔組合物 | |
UA110612C2 (uk) | Похідні 1-аміно-2-циклопропілетилборонової кислоти | |
EP2680849A4 (en) | 6-ALKYL-N- (PYRIDIN-2-YL) -4-ARYLOXYPICOLINAMIDE ANALOGUES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR5 AND PROCESS FOR PREPARING AND USING SAME | |
BR112015012918A2 (pt) | composições para cuidado oral contendo zinco e fluoreto estável | |
EP2547333A4 (en) | STABLE BORTEZOMIB FORMULATIONS | |
EA201590161A1 (ru) | Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона | |
BR112013010694A2 (pt) | composições antitranspirantes ativas e sua produção | |
FR2960749B1 (fr) | Contenant cosmetique | |
MX2013004981A (es) | Composiciones y metodos para la administracion de agentes terapeuticos. | |
MY182328A (en) | Pyridine-2-amides useful as cb2 agonists | |
EP2949647A4 (en) | DETERIORIC PHENYL AMINOPYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
EP2552447A4 (en) | STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB | |
MX352553B (es) | Composicion para el cuidado oral comprendiendo un compuesto de amadori. | |
TR201009167A2 (tr) | Sefalosporin içeren farmasötik granüller. | |
IN2015DN02358A (da) | ||
EP2854888A4 (en) | LIPOIC ACID COMPOSITIONS FOR USE AS ANTIMICROBIAL AGENTS | |
PH12014501304A1 (en) | Oral care compositions | |
EA201500313A1 (ru) | Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие | |
IN2015DN04074A (da) | ||
MX2015011505A (es) | Compuestos para la diferenciacion de celulas madre mejorada en hepatocitos. | |
ES1076415Y (es) | Contenedor de baterias antivandalico enterrado | |
MX2012012824A (es) | Composiciones de productos terapeuticos de moleculas pequeñas. | |
IL239123A0 (en) | Two component compositions containing zinc conjugates amino acid halide and cysteine | |
ZA201503691B (en) | Two component compositions containing zinc amino acid halide complexes and cysteine |